Lumiere Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -19.25%
- Profit Growth -82.77%
- Ebitda -68.96%
- Net Worth 7.77%
- Total Assets -21.32%
About Lumiere Life Sciences
Lumiere Life Sciences Private Limited (LLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 August 2012 and has a history of 12 years and six months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Zachariah Philip and Ketankumar Oza serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51397GJ2012PTC071531
-
Company No.
071531
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Aug 2012
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Lumiere Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Zachariah Philip
|
Director | 14-Aug-2012 | Current |
|
Ketankumar Oza
|
Additional Director | 10-Oct-2012 | Current |
Financial Performance of Lumiere Life Sciences.
Lumiere Life Sciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 19.25% decrease. The company also saw a substantial fall in profitability, with a 82.77% decrease in profit. The company's net worth moved up by a moderate rise of 7.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lumiere Life Sciences?
In 2018, Lumiere Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shiphil Healthcare Products Private LimitedZachariah Philip and Ketankumar Oza are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lumiere Life Sciences?
Unlock and access historical data on people associated with Lumiere Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lumiere Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lumiere Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
